8
Catalog #P2003E0
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| P2003E0 | 100µg | $440.00 | ||
| P2003E0 | 1 mg | $2,400.00 |
| Expression System | E.coli |
|---|---|
| Protein Tag | No tag |
| Purity | > 90% by SDS-PAGE under reducing conditions |
| Endotoxin | < 1 EU per ug by the LAL method |
| Activity | Positive |
| Conjugate | Unconjugated |
| Species | Human |
| Accession Number | P70380-1 |
| Protein Sequence | Asn36-Ser192 |
| Molecular Weight | The protein has a predicted MW of 18 kDa and migrates at approximately 19 kDa on SDS-PAGE with DTT-reduced condition. |
| Formulation | Lyophilized powder from 0.22um filtered solution in PBS, pH 7.4, 22% trehalose |
| Purification | SEC |
| Applications | ELISA |
| Format | Lyophilized |
| Reconstitution | Centrifuge the tube before opening. Recommend reconstitute to a concentration > 100 ug/ml |
| Shipping Condition | Ambient |
| Storage/Shelf Life | <-20 °C for 12 months from the date of receipt; -80°C for 3 months after reconstitution. |
| Background Information | Interleukin-18 (IL-18) is a pro-inflammatory cytokine belonging to the IL-1 family, playing a crucial role in innate and adaptive immunity. It is primarily produced by macrophages, dendritic cells, and epithelial cells. IL-18 binds to the IL-18 receptor (IL-18R) and, in combination with IL-12, enhances IFN-γ production from NK cells and T cells, promoting a Th1 immune response. It also influences inflammatory pathways in autoimmune diseases and cancer. |